(Q46565058)

23 December 2017

title

Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone (English)

1 reference

23 December 2017

0 references

0 references

1 reference

2

1 reference

23 December 2017

author name string

G Martinotti

series ordinal

1

1 reference

23 December 2017

M Di Giannantonio

series ordinal

3

1 reference

23 December 2017

L Janiri

series ordinal

4

1 reference

23 December 2017

language of work or name

English

0 references

publication date

30 May 2008

1 reference

23 December 2017

Journal of Psychopharmacology

published in

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

2

1 reference

23 December 2017

page(s)

123-129

1 reference

23 December 2017

How many cravings? Pharmacological aspects of craving treatment in alcohol addiction: a review.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Baclofen: a new drug for the treatment of alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Aripiprazole in schizophrenia with cocaine dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Dopamine partial receptor agonists reduce ethanol intake in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Bromocriptine in the prevention of alcohol abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

D3 receptor test in vitro predicts decreased cocaine self-administration in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Patients with schizophrenia treated with aripiprazole, a multicentre naturalistic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

A psychobiological model of temperament and character

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

A one-year pragmatic trial of naltrexone vs disulfiram in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

The effect of olanzapine on craving and alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

The Italian version of the Obsessive-Compulsive Drinking Scale: validation, comparison with the other versions, and difference between type 1- and type 2-like alcoholics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Benzodiazepine treatment for alcohol-dependent patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Efficacy and safety of aripiprazole in alcohol dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Aripiprazole in the treatment of patients with borderline personality disorder: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

The neural basis of drug craving: an incentive-sensitization theory of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Dual dopamine/serotonin releasers as potential medications for stimulant and alcohol addictions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Tiapride in the long-term management of alcoholics of anxious or depressive temperament.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Clinical effects and adverse reactions of off-label use of aripiprazole in children and adolescents with developmental disabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

Aripiprazole reduces alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881108089596

21 January 2018

Identifiers

DOI

10.1177/0269881108089596

1 reference

23 December 2017

1 reference

23 December 2017